These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26745128)

  • 1. Primary Idiopathic Myelofibrosis: Clinico-Epidemiological Profile and Risk Stratification in Pakistani Patients.
    Sultan S; Irfan SM
    Asian Pac J Cancer Prev; 2015; 16(18):8629-31. PubMed ID: 26745128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-Hematological Profile and Risk Stratification in Patients with Essential Thrombocythemia: Experience from Pakistan.
    Sultan S; Irfan SM; Tanveer Q; Ali N
    Asian Pac J Cancer Prev; 2015; 16(17):7659-61. PubMed ID: 26625777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-Epidemiological Profile of Patients with Polycythaemia Rubra Vera - a Five Year Experience from a Tertiary Care Center.
    Sultan S; Irfan SM; Murad S
    Asian Pac J Cancer Prev; 2016; 17(3):1531-3. PubMed ID: 27039801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Promyelocytic Leukemia: a Single Center Study from Southern Pakistan.
    Sultan S; Irfan SM; Ashar S
    Asian Pac J Cancer Prev; 2015; 16(17):7893-5. PubMed ID: 26625817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-hematological profile of patients with B-chronic lymphoid leukemia in Pakistan.
    Zeeshan R; Sultan S; Irfan SM; Kakar J; Hameed MA
    Asian Pac J Cancer Prev; 2015; 16(2):793-6. PubMed ID: 25684527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Lymphoblastic Leukemia in Adults - an Analysis of 51 Cases from a Tertiary Care Center in Pakistan.
    Sultan S; Irfan SM; Parveen S; Mustafa S
    Asian Pac J Cancer Prev; 2016; 17(4):2307-9. PubMed ID: 27221935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK-2 V617F Mutational Analysis in Primary Idiopathic Myelofibrosis: Experience from Southern Pakistan.
    Sultan S; Irfan SM
    Asian Pac J Cancer Prev; 2015; 16(17):7889-92. PubMed ID: 26625816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.
    Deadmond MA; Smith-Gagen JA
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2131-8. PubMed ID: 25968903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Myeloma: a Retrospective Analysis of 61 Patients from a Tertiary Care Center.
    Sultan S; Irfan SM; Parveen S; Ali H; Basharat M
    Asian Pac J Cancer Prev; 2016; 17(4):1833-5. PubMed ID: 27221861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-Pathological Profile And Outcomes Of Patients With Polycythaemia Vera, Essential Thrombocythaemia And Idiopathic Myelofibrosis: A Tertiary Care Center Experience From Southern Pakistan.
    Shaikh MS; Shaikh MU; Adil SN; Khurshid M; Ahmed ZA
    J Ayub Med Coll Abbottabad; 2016; 28(2):293-297. PubMed ID: 28718562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2014 Sep; 89(9):915-25. PubMed ID: 25124313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canonical Wnt/β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis.
    Lucijanic M; Livun A; Tomasovic-Loncaric C; Stoos-Veic T; Pejsa V; Jaksic O; Prka Z; Kusec R
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):523-526. PubMed ID: 27381374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Duangnapasatit B; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L
    Asian Pac J Cancer Prev; 2015; 16(12):5013-8. PubMed ID: 26163633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and Pattern of Bone Marrow Infiltration in Classical Hodgkin's Lymphoma: Experience from Southern Pakistan.
    Sultan S; Irfan SM; Parveen S; Haider SA; Masood M
    Asian Pac J Cancer Prev; 2016; 17(4):1857-9. PubMed ID: 27221865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplant strategies for idiopathic myelofibrosis.
    McCarty JM
    Semin Hematol; 2004 Apr; 41(2 Suppl 3):23-9. PubMed ID: 15190520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2016 Dec; 91(12):1262-1271. PubMed ID: 27870387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
    Buhr T; Georgii A; Choritz H
    Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review.
    Mitra D; Kaye JA; Piecoro LT; Brown J; Reith K; Mughal TI; Sarlis NJ
    Cancer Med; 2013 Dec; 2(6):889-98. PubMed ID: 24403262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.